Becton, Dickinson and Company Buyback
OLI recorded this information on 11/4/2021
Company:
Becton, Dickinson and Company
Buyback:
BDX buyback
Share Amount Authorized:
10,000,000
Buyback Details:
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, an increase of 4.8% from the previous quarter. The dividend will be payable on Dec. 31, 2021 to holders of record on Dec. 10, 2021. The indicated annual dividend rate for fiscal year 2022 is $3.48 per share. The board has also authorized the company to repurchase up to 10 million shares of BD common stock. This new authorization is in addition to the approximately 750,000 shares that remain available under the board's previous authorization in 2013. The authorizations provide the company the ability to repurchase shares of its common stock through open market purchases, privately negotiated transactions or other methods. The actual timing, manner, number and value of any shares repurchased will be determined by management at its discretion and will depend on a number of factors, including the market price of BD's common stock, general market and economic conditions, and other business considerations.
Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s operations consist of three business segments: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems; and BD Interventional, which provides vascular, urology, oncology and surgical products.
Becton Dickinson SEC Filing Email Alerts Service
Preferred: BDXB
Open the BDX Page at The Online Investor »
|
||||||||||||||||||||||||
Open the BDX Page at The Online Investor (in a new window) »
 Free BDX Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Strong Buy (3.53 out of 4) 60th percentile
(ranked higher than approx. 60% of all stocks covered)
Analysts' Target Price: BDX Stock Forecast Based on Zacks ABR data; powered by Xignite |
